Antibody Design Labs™ is committed to become a leader in the field of recombinant antibody technologies. Over the last 30 years, techniques have rapidly evolved to make antibodies a primary component of modern research, modern diagnostic, and emerging therapeutics. Following the initial discovery of monoclonal hybridomas, technologies such as phage display have become routine in many laboratories. Still, getting the right antibody for the right application can be a long journey where high-throughput approaches can be very effective but at prohibitive costs. Antibody Design Labs™ will be a centralized place to access tools, information, techniques in the field of recombinant antibody generation, engineering and design.